Ozyerli-Goknar, E., Kala, E., Aksu, A., Bulut, I., Cingöz, A., Nizamuddin, S., . . . Bagci-Onder, T. (2023). Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival. BioMed Central.

Ozyerli-Goknar, E., et al. Epigenetic-focused CRISPR/Cas9 Screen Identifies (absent, Small, or Homeotic)2-like Protein (ASH2L) as a Regulator of Glioblastoma Cell Survival. BioMed Central, 2023.

Ozyerli-Goknar, E., et al. Epigenetic-focused CRISPR/Cas9 Screen Identifies (absent, Small, or Homeotic)2-like Protein (ASH2L) as a Regulator of Glioblastoma Cell Survival. BioMed Central, 2023.